Tagged with Switzerland

Switzerland Philippe de Saab, Vice President, Vision Care at Bausch + Lomb, outlines the company’s strategy amid rising global demand for contact lenses. He highlights innovations in contact lenses, a localised approach across 50 diverse markets and efforts to expand patient access through professional partnerships – all built on Bausch +…

Switzerland Marcel Imwinkelried, CEO of Siegfried, leads a CDMO specialising in small molecules with comprehensive global manufacturing capabilities. His “Evolve Plus” strategy focuses on operational excellence, selective biologics growth, and disciplined acquisitions to ensure sustainable expansion. Under his leadership, Siegfried prioritises innovation, sustainability, and talent development to deliver lasting value to…

Switzerland Eight years after establishing its Swiss affiliate as a one-man operation, Accord Healthcare has built a strong position in one of Europe’s most competitive markets, with a focused strategy in oncology, rheumatology, and neurology. In this interview, Country Director and General Manager Richard Hummel reflects on the affiliate’s rapid growth,…

argenx Carl-Michael Simon, Country Manager for Mid-Size Markets at argenx, discusses how the company has grown from its Dutch and Belgian origins into a global biotech delivering precision medicines for autoimmune diseases. From the landmark approval of VYVGART to new formulations, market access strategies, and the ambitious goal of reaching 50,000…

Switzerland Dr. Dragan Grabulovski, CEO and co-founder of Araris, shared how his journey from co-founding Covagen to advising venture firms shaped his vision for building a platform-driven biotech company. He explained how Araris’s proprietary conjugation technology solves key limitations in ADC development, including enabling multi-payload approaches for greater efficacy. “Our vision…

Switzerland Henric Bjarke, CEO of Tenpoint Therapeutics with offices in Basel, Switzerland, highlights the company’s de-risked presbyopia program, strong team, and large global market. With a career spanning landmark launches like latanoprost and anti-VEGF therapies, he describes the enduring pull of ophthalmology. Tenpoint is preparing for the 2026 launch of its…

Switzerland New Idorsia CEO Srishti Gupta is emphasising “financial discipline” as she looks to turn around the fortunes of one of Europe’s top biotechs.   Challenging Times Gupta, who spent almost two decades at consultancy firm McKinsey, inherits a company that managed to launch three drugs in its first seven years…

Switzerland As Medinova marks 80 years since its founding in Zurich, General Manager Olga Lamua Olivar is charting the path forward for the boutique specialty pharma player. With a career spanning multiple countries and disciplines, she brings the breadth of experience needed to guide Medinova through its next transformation. Her strategy…

Switzerland Amid structural reforms and shifting expectations across the Swiss healthcare system, Marco Caruso’s return to Medtronic marks a renewed focus on patient impact, equitable access, and long-term value. Speaking from the intersection of leadership, policy, and innovation, Caruso offers sharp insights into how one of the world’s largest medtech companies…

Gilead With more than 20 years of experience in the pharmaceutical industry and a track record at companies such as MSD, Abbott (later AbbVie), Eisai and AstraZeneca, Stuart Head brings a deep well of expertise to the Swiss affiliate. His career spans multiple therapeutic areas, including oncology, immunology, and respiratory diseases.…

Switzerland Dr Srishti Gupta brings a distinctive combination of medical training, health policy insight, and strategic consulting to her role as CEO of Idorsia Pharmaceuticals. A Harvard-trained biochemist and physician, she spent 18 years at McKinsey & Company advising life sciences and global health clients. Committed to reducing healthcare inequities and…

Switzerland Maximilian Schrems,  Managing Director of VTU Engineering AG (Switzerland), brings a distinctive background in architecture and structural engineering to pharmaceutical engineering, an advantage when integrating complex process requirements with advanced facility design. Under his leadership, VTU emphasises operational excellence, high-performance culture, and nearshoring across Europe to ensure project continuity and…